Unilever strategy under scrutiny after short-lived GSK skirmish
Go back to Unilever strategy under scrutiny after short-lived GSK skirmish| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.41 +0.45 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.35 | 52 Week Low | $37.82 | |||
| Day High | $52.57 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 2,388,455 | |||||
| UNILEVER PLC (NYSE: UL) | Delayed: 64.14 +0.74 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.40 | 52 Week High | $48.97 | |||
| Open | $63.31 | 52 Week Low | $39.06 | |||
| Day High | $64.18 | P/E | N/A | |||
| Day Low | $63.22 | EPS | $0.00 | |||
| Volume | 2,643,151 | |||||
